Clinical Trials

2 results for Bladder Cancer

Phase II Study to Evaluate the Activity of Commercially Available Molecularly Matched Targeted Therapies in Selected Tumor Types Based on Genomic Alterations

  • Condition: Non-small Cell Lung Carcinoma, Urothelial Carcinoma, Gastrointestinal Carcinoma, Non-colon, Upper Aerodigestive Tract Carcinoma
  • Intervention: Drug: afatinib, Drug: regorafenib
  • Study ID: NCT02795156
View Trial

Peking University First Hospital

  • Condition: Upper Tract Urothelial Carcinoma, Bladder Recurrence
  • Intervention: Drug: Pirarubicin
  • Study ID: NCT02740426
View Trial